Loading…
Viemed Healthcare, Inc. is projected to rise to $17.53 by 2027, a +42% move from its current price of $12.31. VMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $12.13 | $12.32 | $12.51 | +0.06% |
| Jul 14 | $12.06 | $12.32 | $12.59 | +0.11% |
| Jul 15 | $12.01 | $12.33 | $12.66 | +0.17% |
| Jul 16 | $11.97 | $12.34 | $12.72 | +0.23% |
| Jul 17 | $11.93 | $12.35 | $12.77 | +0.29% |
| Jul 18 | $11.90 | $12.35 | $12.82 | +0.34% |
| Jul 19 | $11.87 | $12.36 | $12.87 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.87 | $12.36 | $12.87 | +0.40% |
| Week 2 | $11.72 | $12.41 | $13.13 | +0.81% |
| Week 3 | $11.62 | $12.46 | $13.36 | +1.21% |
| Week 4 | $11.54 | $12.51 | $13.55 | +1.62% |
| Week 5 | $11.48 | $12.56 | $13.74 | +2.02% |
| Week 6 | $11.43 | $12.61 | $13.91 | +2.43% |
| Week 7 | $11.39 | $12.66 | $14.08 | +2.85% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Viemed Healthcare, Inc. (VMD) operates in the Healthcare sector, focusing on home medical equipment and post-acute respiratory care in the United States. Its offerings include respiratory disease management solutions, including non-invasive ventilation, percussion vests, and other therapies for COPD, as well as invasive and non-invasive ventilation and related equipment and supplies.
The company also sells and rents HME devices such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, oxygen concentrators, and other medical equipment. In addition, Viemed provides neuromuscular care and oxygen therapy services, sleep apnea management with PAP and related devices, in-home sleep apnea testing services, and breast pumps and related lactation equipment and supplies, along with healthcare staffing and recruitment services. Viemed Healthcare, Inc.
was founded in 2006 and is headquartered in Lafayette, Louisiana.
Viemed Healthcare, Inc. trades under the symbol VMD and is categorized in Healthcare. The current price is $12.31 with a market capitalization of $471.93M and a market rank of 3087.
The stock shows a bullish technical backdrop with a 30-day range of $11.14 to $13.60, a 50-day SMA of $10.31, and a 200-day SMA of $8.43. Support is at $9.48 and resistance at $12.31. The annualized volatility stands at 30%.
The long-run price forecast projects a rising path from a 2026 average of $12.31 to substantial upside by 2050, with an average price of $272.57 and an ROI of 2114.2%. The trajectory remains bullish across the forecast years with varying levels of upside.
A major floor 31.8% below — a decisive break under it would weaken the trend.
The nearest floor, 23.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 15.3% above — clearing it would confirm fresh momentum.
Key VMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.18 | Buy | $12.15 | Buy |
| MA 10 | $11.91 | Buy | $11.90 | Buy |
| MA 20 | $11.34 | Buy | $11.43 | Buy |
| MA 50 | $10.31 | Buy | $10.61 | Buy |
| MA 100 | $9.76 | Buy | $9.84 | Buy |
| MA 200 | $8.43 | Buy | $8.96 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 78.70 | Sell |
| Stoch RSI (14) | 88.72 | Sell |
| CCI (20) | 105.10 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 12.52 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.74 | Buy |
| Awesome (5,34) | 1.47 | Buy |
| Ultimate (7,14,28) | 89.36 | Sell |
| Momentum (10) | 0.62 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 12.35 | Sell |
| ADX (14) | 39.93 | Buy |
| ATR (14) | 0.15 | Info |
The near-term picture is bullish, with the 30-day range spanning $11.14 to $13.60 and the current price at $12.31. The RSI(14) is 80, indicating strong momentum. The stock sits above the 50-day SMA of $10.31 and the 200-day SMA of $8.43, with support at $9.48 and resistance at $12.31.
The annualized volatility is 30%, highlighting notable near-term movement potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.22 | $12.31 | $16.81 | 0% | Neutral | |
| $14.36 | $17.53 | $22.38 | +42% | Bullish | |
| $17.74 | $22.07 | $28.94 | +79% | Bullish | |
| $22.69 | $28.66 | $38.38 | +133% | Bullish | |
| $25.56 | $32.72 | $44.60 | +166% | Bullish | |
| $28.39 | $36.78 | $50.93 | +199% | Bullish | |
| $32.41 | $42.48 | $59.66 | +245% | Bullish | |
| $34.74 | $46.01 | $65.45 | +274% | Bullish | |
| $43.32 | $57.94 | $83.41 | +371% | Bullish | |
| $53.31 | $71.97 | $104.76 | +485% | Bullish | |
| $77.53 | $109.17 | $166.53 | +787% | Bullish | |
| $180.48 | $272.57 | $445.67 | +21.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.22 | $12.31 | $14.49 | +0.00% |
| August 2026 | $10.74 | $12.57 | $15.04 | +2.13% |
| September 2026 | $11.03 | $12.97 | $15.63 | +3.16% |
| October 2026 | $10.98 | $12.96 | $15.73 | -0.05% |
| November 2026 | $11.06 | $13.11 | $15.99 | +1.09% |
| December 2026 | $11.53 | $13.71 | $16.81 | +4.61% |
Click any year to see its month-by-month VMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VMD is projected to trade between $7.22 and $16.81, averaging $12.31 — a potential gain of 0% from today's $12.31. Price action looks broadly range-bound.
Viemed Healthcare, Inc.'s 2027 outlook centres on $17.53, within a $14.36 to $22.38 range. That is up +42% on the projected 2026 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, VMD could reach as high as $28.94, with a base case around $22.07 and support toward $17.74 — roughly +79% from $12.31. Momentum favours further upside here.
Expect VMD to range from $22.69 to $38.38 through 2029. The $28.66 average target implies a +133% move from current prices. That is up +30% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The VMD price prediction for 2030 points to an average of $32.72 (low $25.56, high $44.60) — a potential gain of +166% on today's $12.31. Momentum favours further upside here.
In 2031, VMD is projected to trade between $28.39 and $50.93, averaging $36.78 — a potential gain of +199% from today's $12.31. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Viemed Healthcare, Inc.'s 2032 outlook centres on $42.48, within a $32.41 to $59.66 range. That is up +15% on the projected 2031 average. That marks a +245% change versus current levels. Momentum favours further upside here.
By 2033, VMD could reach as high as $65.45, with a base case around $46.01 and support toward $34.74 — roughly +274% from $12.31. Buyers look set to stay in control over this stretch.
Expect VMD to range from $43.32 to $83.41 through 2034. The $57.94 average target implies a +371% move from current prices. That is up +26% on the projected 2033 average. Momentum favours further upside here.
The VMD price prediction for 2035 points to an average of $71.97 (low $53.31, high $104.76) — a potential gain of +485% on today's $12.31. Buyers look set to stay in control over this stretch.
In 2040, VMD is projected to trade between $77.53 and $166.53, averaging $109.17 — a potential gain of +787% from today's $12.31. That is up +52% on the projected 2035 average. Momentum favours further upside here.
Viemed Healthcare, Inc.'s 2050 outlook centres on $272.57, within a $180.48 to $445.67 range. That is up +150% on the projected 2040 average. That marks a +21.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in VMD today (≈ 81.234768 VMD) could be worth
$22,141.77
+$21,141.77 (+2114%) by 2050 · US Dollar
Based on the average projected VMD price of $272.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VMDwould be worth at today's price.
$1,000 invested in VMD on Jul 10, 2025 (≈ 143.266475 VMD) would be worth
$1,763.61
+$763.61 (+76.4%) today · 1.76× · US Dollar
Based on a VMD entry price of $6.98 vs. today's $12.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.02 | $1,024.13 | +2.4% |
| 1 month ago | $10.13 | $1,215.2 | +21.5% |
| 3 months ago | $9.51 | $1,294.43 | +29.4% |
| 6 months ago | $7.3 | $1,686.3 | +68.6% |
| 1 year ago | $6.98 | $1,763.61 | +76.4% |
| All time (5.0y) ago | $6.91 | $1,781.48 | +78.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VMD forecast.
Our base-case forecast reaches $25.00 around 2029.
Implied market cap at $25.00: $958.42M
The multi-year forecast shows a bullish trajectory, beginning with a 2026 average of $12.31 and a 0% ROI. In 2027 the average rises to $17.53 with a 42.4% ROI, followed by $22.07 in 2028 (79.3%), $28.66 in 2029 (132.8%), and $32.72 in 2030 (165.8%). The path continues to 2031 at $36.78 (198.8%), 2032 at $42.48 (245.1%), 2033 at $46.01 (273.7%), 2034 at $57.94 (370.6%), and 2035 at $71.97 (484.7%).
By 2040 the forecast shows $109.17 (786.9%), and by 2050 the average reaches $272.57 with a max of $445.67 and a 2114.2% ROI, all of which are bullish signals. These figures are estimates and not guarantees, and actual results can vary.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $25.56, an avg of $32.72, a max of $44.60, and a ROI of 165.8% with bullish sentiment.
The forecast indicates bullish sentiment from 2027 onward, with averages rising to $17.53 (2027), $32.72 (2030), up to a 2050 average of $272.57 and an ROI of 2114.2%. These are estimates, not guarantees.
Yes. The forecast shows a 2040 average of $109.17 and a 2040 max of $166.53, implying price levels above $100 in that period.
RSI(14) is 80 with a 30-day range of $11.14 to $13.60. The stock trades with a 50-day SMA of $10.31 and a 200-day SMA of $8.43, with support at $9.48 and resistance at $12.31; current price is $12.31. The sentiment is bullish.
Current price is $12.31 and market cap is $471.93M; the stock ranks 3087.
Viemed Healthcare, Inc. Community Discussion
0Share your Viemed Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.